Loading insider details...
Beta
Latest Form 4 (Sep 10, 2026): Purchase of 100,000 GRCE shares, $214.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 10, 2026 | Grace Therapeutics, Inc. (GRCE) | Purchase | 100,000 | $214.0K |
| Sep 1, 2026 | Grace Therapeutics, Inc. (GRCE) | Grant/Award | 267,160 | n/a |
| Apr 17, 2025 | Grace Therapeutics, Inc. (GRCE) | Grant/Award | 225,400 | n/a |
| May 8, 2024 | Acasti Pharma Inc. (ACST) | Grant/Award | 128,770 | n/a |
| Dec 20, 2023 | Acasti Pharma Inc. (ACST) | Grant/Award | 41,668 | n/a |
| Jul 18, 2023 | Acasti Pharma Inc. (ACST) | Grant/Award | 208,334 | n/a |